Open AccessEFIKASI TERAPI EPIDERMAL GROWTH FACTOR RECEPTOR-TYROSINE KINASE INHIBITOR (EGFR-TKIs) PADA KANKER PARU
Author(s) -
Fitri Wulandari,
Widyaningrum Utami,
Evieta Rohana,
Wimzy Rizqy Prabhata
Publication year - 2021
Publication title -
generics journal of research in pharmacy
Language(s) - Uncategorized
Resource type - Journals
ISSN - 2774-9967
DOI - 10.14710/genres.v1i1.9870
Subject(s) - erlotinib , medicine , afatinib , gefitinib , lung cancer , epidermal growth factor receptor , cancer research , microbiology and biotechnology , gynecology , oncology , biology , cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom